1,3-xylenediamine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 15133 |
| CHEMBL ID | 384146 |
| SCHEMBL ID | 36008 |
| MeSH ID | M0183503 |
| Synonym |
|---|
| LS-13448 |
| nsc61568 |
| m-diaminoxylene |
| mxda |
| nsc-61568 |
| m-xylylene amine |
| .alpha.,.alpha.'-diamino-m-xylene |
| 1,3-bis(aminomethyl)benzene |
| 1,3-bis-aminomethylbenzen |
| m-xylylenediamine |
| .alpha.,.alpha.'-m-xylenediamine |
| m-phenylenebis(methylamine) |
| 1477-55-0 |
| m-xylylendiamin |
| m-xylene-.alpha.,.alpha.'-diamine |
| methylamine, m-phenylenebis- |
| 1,3-benzenedimethanamine |
| 1,3-xylylenediamine |
| alpha,alpha'-diamino-m-xylene |
| ai3-25033 |
| einecs 216-032-5 |
| 1,3-xylenediamine |
| 1,3-bis-aminomethylbenzen [czech] |
| ccris 6681 |
| m-xylene-alpha,alpha'-diamine |
| m-xylylendiamin [czech] |
| brn 1099911 |
| nsc 61568 |
| hsdb 6257 |
| fdlqzkylhjjbhd-uhfffaoysa- |
| inchi=1/c8h12n2/c9-5-7-2-1-3-8(4-7)6-10/h1-4h,5-6,9-10h2 |
| m-xylylenediamine, 99% |
| 1,3-phenylenedimethanamine |
| AC-11133 |
| m-xylene diamine |
| 3-(aminomethyl)benzylamine |
| (3-(aminomethyl)phenyl)methanamine |
| CHEMBL384146 |
| [3-(aminomethyl)phenyl]methanamine |
| AKOS000119451 |
| NCGC00248826-01 |
| 1e84b9yljd , |
| ec 216-032-5 |
| unii-1e84b9yljd |
| cas-1477-55-0 |
| NCGC00257445-01 |
| tox21_303362 |
| dtxsid9029649 , |
| dtxcid909649 |
| NCGC00258320-01 |
| tox21_200766 |
| FT-0629046 |
| xylenediamine, m- |
| 1,3-benzenedimethanamine [hsdb] |
| SCHEMBL36008 |
| aminomethyl-3-aminomethylbenzene |
| metaxylylenediamine |
| m-xylylene diamine |
| metaxylylene diamine |
| m-(aminomethyl)benzylamine |
| epilink mx |
| 3-(aminomethyl)benzylamine # |
| Q-200398 |
| mfcd00008119 |
| m-xylylenediamine, purum, >=98.0% (nt) |
| 3-aminomethyl-benzylamine |
| Q15726051 |
| EN300-20441 |
| 1,3-benzenebis(methylamine) 100 microg/ml in acetonitrile |
| 1,3-benzenebis(methylamine) |
| F71376 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| acetylcholinesterase | Homo sapiens (human) | Potency | 88.0011 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395; AID1347398 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 29.7477 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 73.7180 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 33.4067 | 0.0002 | 29.3054 | 16,493.5996 | AID743075; AID743080 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 62.8129 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 59.2418 | 0.0003 | 23.4451 | 159.6830 | AID743065 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID273097 | Activity of human SSAO measured as hydrogen peroxide production at 1 mM relative to benzylamine oxidation | 2006 | Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21 | New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. |
| AID273098 | Activity of mouse SSAO measured as hydrogen peroxide production at 100 uM relative to benzylamine oxidation | 2006 | Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21 | New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (5.88%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 2 (11.76%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (82.35%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Instability of an aromatic amine in fatty food and fatty food simulant: characterisation of reaction products and prediction of their toxicity. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, Volume: 32, Issue: 1 | 2015 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |